Improving interventions and reducing invasive investigations in cardiovascular disease

Improving interventions and reducing invasive investigations in cardiovascular disease

Despite being one of the most preventable and intervenable health conditions, cardiovascular disease (CVD) is responsible for one in four premature deaths in the UK and accounts for the largest gap in healthy life expectancy. It is identified as the single biggest condition where lives can be saved by the NHS over the next 10 years. As such, the NHS has an ambition to help prevent over 150,000 heart attacks, strokes and dementia cases over the next 10 years. What innovations could be deployed to help solve this significant, unmet health need?

Find your nearest AHSN

Coordinates

Overview

CVD is one of the main causes of death and disability in the UK. The number of people living with heart and circulatory diseases is more than double the combined total of those with cancer and Alzheimer’s disease. As well as being devastating for patients and their families, strokes are estimated to directly cost the NHS around £3 billion per year, with additional costs to the wider economy of a further £4 billion in lost productivity, disability and informal care.  

This Innovation Exchange will look at all aspects of improving CVD management, from prevention to treatment and self-management. 

Prevention is at the heart of our vision for improving the health of the nation, empowering people to stay healthy, not just treating them when they’re ill. Almost half of those with high blood pressure are going about their daily lives without it being detected or treated. Millions of people are needlessly at risk of heart attacks or strokes when it could be prevented.

- Health Secretary Matt Hancock 

How can innovation help?

We’d love your feedback, as an innovator, to the following challenge questions. Please contact our Innovation Project Manager, Karla Richards (karlarichards@nhs.net). 

  • How does your innovation help prevent CVD and how can the NHS use this to improve patient outcomes and make financial savings? 
  • How can CVD be detected more efficiently and in a less invasive way? 
  • How can technology help make CVD interventions more efficient, accurate, predictable and non-invasive and provide better patient outcomes?  
  • How can digital technology support cardiology service re-design through the reorganisation of pathology and diagnostic imaging services? 
  • How can we ensure new technology will be acceptable to patients, the people important to them and to professionals? 
  • What novel technologies could facilitate a change in the types of patients or the types of conditions which could be monitored, and the ease of doing so? 

Desired impact / outcomes

The desired outcomes of this innovation exchange are: 

  • Showcasing innovations for CVD prevention, management and treatment to health and care professionals  
  • Valuable feedback for innovators from local decision makers, healthcare practitioners and patients 
  • Valuable networking opportunities for innovators 
  • Future partnerships between innovators and health and care teams formed 

Status: Active